| |
|
|
|
Corvus Pharmaceuticals Inc.  
|
|
4.4 -0.62 (-0.12%) |
07-10 16:00 |
|
Open: |
4.75 |
Pre close: |
5.02 |
Target:
|
6.09 
|
|
High: |
4.79 |
Low: |
4.39 |
Resistance:
|
5.21
6.88
|
|
Volume: |
1,709,983 |
Market Cap: |
123M |
Support:
|
2.51
2.09
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.50
 |
MACD |
MACD(12,26):
|
0.34 |
|
MA(20): |
3.33 |
Signal(12,26,9): |
0.10 |
|
MA(100): |
3.00 |
Stochastic Oscillator |
%K(14,3):
|
55.38 |
|
MA(250): |
3.61 |
%D(3): |
54.69 |
|
Average Volume(K) |
3-Month: |
200895
|
52-Week |
High:
|
6.88 |
|
10-Days: |
1133449 |
Low: |
1.01 |
|
RSI |
RSI(14):
|
61.49 |
Change(%): |
-27.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.633 |
Return on Equity (ttm) |
-59.7 |
Shares Out. (M) |
27.95 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-33.5 |
Shares Float (M) |
10.92 |
|
EPS Est. Next Year |
-3.410 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.31 |
|
EPS Est. Next Quarter |
-0.840 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
75.64 |
|
Forward EPS |
-1.590 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
423 |
|
Book Value (p.s.) |
2.150 |
EBITDA (p.s.) |
-1.756 |
P/E |
-2.69 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.05 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-37.68 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-20.16 |
P/CF |
-3.26 |
|
|
|
|
|
|
